Lincoln Pharmaceuticals Limited (LINCOLN) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE405C01035
Key metrics
- Market Cap
- ₹1,221 Cr
- P/E Ratio
- 12.66
- EPS
- 48.18
- Book Value
- 378.25
- P/B Ratio
- 1.62
- ROE
- 11.6%
- ROCE
- 10.92%
- Debt / Equity
- 0.01
- Net Margin
- 13.1%
- Revenue Growth
- 7.67%
- Profit Growth
- 6.74%
- Dividend Yield
- 0.3%
- 52W High
- ₹770.00
- 52W Low
- ₹440.00
- Market Cap Band
- small cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Lincoln Pharmaceuticals Limited
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Promoter Holding
- 56.12%
The full Lincoln Pharmaceuticals Limited analysis
Create a free account to open the complete LINCOLN deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.